...
首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine.
【24h】

Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine.

机译:用氯喹或磺胺多辛加乙胺嘧啶治疗的单纯性恶性疟原虫疟疾发作患者的配子细胞减少症和对蚊子的感染性。

获取原文
获取原文并翻译 | 示例
           

摘要

Plasmodium falciparum gametocytemia and its related infectivity for mosquitoes was studied in 115 patients (median age = 18 years, range = 4-45) with simple malaria attacks who lived in the hypoendemic area of Dakar, Senegal. Patients were included in a 28-day in vivo sensitivity test after treatment with chloroquine (CQ, n = 82) or sulfadoxine plus pyrimethamine (SP, n = 33). The prevalence of resistant infections was 58.5% in those treated with CQ and 0% in those treated with SP. The gametocytemia peaked at day 7 after treatment. The maximal gametocyte prevalence was 38.2% in the CQ-sensitive infection group, 89.6% in the CQ-resistant group, and 97.0% in those treated with SP The maximal geometric mean gametocytemia was 2.19/microl in the CQ-sensitive infection group, 29.12/microl in the CQ-resistant group and 85.55/microl in those treated with SP. The period between appearance of the first clinical symptom and treatment was positively related to gametocyte prevalence at days 0 and 2. Experimental infection of wild Anopheles arabiensis using membrane feeders was performed at days 0 and 7, and mosquito infectivity was measured by oocyst detection on the midgut. At day 0, 14.1% of the patients had infected at least 1 mosquito, and at day 7, this value was 38.5%. The mean percentage of infected mosquitoes was 3.2% at day 0 and 12.6% at day 7. At day 7 after treatment with CQ, the relative risk for patients with resistant infections of infecting anophelines was 4.07 higher than in those with sensitive infections. No difference was observed in infectivity for mosquitoes between RI-type resistance and the RII + RIII-type resistance. A sporonticidal effect of SP was observed at day 7 after treatment. These data show that P. falciparum gametocytes and their infectivity for mosquitoes were differentiated according to the drug used, its efficacy, and the duration of symptoms before treatment; they were not dependent on the density of asexual stages. Prompt treatment of malaria cases performed at the beginning of symptoms could limit the spread of resistant parasites.
机译:研究了居住在塞内加尔达喀尔低流行地区的115例单纯性疟疾发作的患者(恶性疟原虫配子体细胞瘤及其对蚊子的相关感染性)。用氯喹(CQ,n = 82)或磺胺多辛加乙胺嘧啶(SP,n = 33)治疗后,将患者纳入为期28天的体内敏感性测试。 CQ治疗的耐药性感染率为58.5%,SP治疗的为0%。配子细胞减少症在治疗后第7天达到峰值。 CQ敏感感染组的最大配子细胞患病率为38.2%,CQ耐药组为89.6%,SP治疗组为97.0%。CQ敏感感染组的最大配子几何平均数为2.19 / microl,为29.12。 CQ耐药组中,每微升1微升,用SP处理的患者中每微升85.55微克。从出现第一种临床症状到治疗的时间与第0天和第2天的配子细胞患病率呈正相关。在第0天和第7天,使用膜饲喂器进行了野生阿拉伯按蚊的实验性感染,并通过卵囊检测对蚊子的感染性进行了测量。中肠。在第0天,有14.1%的患者感染了至少1只蚊子,在第7天,该值为38.5%。在第0天,蚊子的平均感染百分比为3.2%,在第7天,蚊子的平均百分比为12.6%。在接受CQ治疗后的第7天,感染性按蚊的耐药感染患者的相对风险比敏感感染的患者高4.07。在RI型和RII + RIII型耐药之间,蚊子的感染性没有差异。在治疗后第7天观察到SP的杀孢子虫作用。这些数据表明,恶性疟原虫配子细胞及其对蚊子的感染性根据所用药物,疗效和治疗前症状的持续时间而有所不同。他们不依赖于无性阶段的密度。在症状开始时对疟疾病例进行及时治疗可能会限制耐药性寄生虫的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号